Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
NeuroMetrix is a medical devices business based in the US. NeuroMetrix shares (NURO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.34 – an increase of 14.51% over the previous week. NeuroMetrix employs 26 staff and has a trailing 12-month revenue of around $3.8 million.
| Latest market close | $4.34 |
|---|---|
| 52-week range | $2.66 - $4.73 |
| 50-day moving average | $4.02 |
| 200-day moving average | $3.83 |
| Wall St. target price | $50.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-4.76 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.97 from 2024-11-19
| 1 week (2024-11-14) | 4.75% |
|---|---|
| 1 month (2024-10-21) | -12.75% |
| 3 months (2024-08-21) | 12.15% |
| 6 months (2024-05-21) | 3.93% |
| 1 year (2023-11-21) | 745.04% |
|---|---|
| 2 years (2022-11-21) | -69.37% |
| 3 years (2021-11-19) | 58.72 |
| 5 years (2019-11-21) | 31.12 |
| Revenue TTM | $3.8 million |
|---|---|
| Gross profit TTM | $5.8 million |
| Return on assets TTM | -28.21% |
| Return on equity TTM | -42.78% |
| Profit margin | -203.71% |
| Book value | $7.99 |
| Market Capitalization | $7.7 million |
TTM: trailing 12 months
We're not expecting NeuroMetrix to pay a dividend over the next 12 months.
NeuroMetrix's shares were split on a 1:8 basis on 21 November 2023 . So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeuroMetrix shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for NeuroMetrix shares which in turn could have impacted NeuroMetrix's share price.
Over the last 12 months, NeuroMetrix's shares have ranged in value from as little as $2.66 up to $4.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeuroMetrix's is 2.301. This would suggest that NeuroMetrix's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NeuroMetrix, Inc. , a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. .
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.